Correlation Between BriaCell Therapeutics and CG Oncology,
Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BriaCell Therapeutics Corp and CG Oncology, Common, you can compare the effects of market volatilities on BriaCell Therapeutics and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and CG Oncology,.
Diversification Opportunities for BriaCell Therapeutics and CG Oncology,
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BriaCell and CGON is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and CG Oncology, go up and down completely randomly.
Pair Corralation between BriaCell Therapeutics and CG Oncology,
Assuming the 90 days horizon BriaCell Therapeutics Corp is expected to generate 3.17 times more return on investment than CG Oncology,. However, BriaCell Therapeutics is 3.17 times more volatile than CG Oncology, Common. It trades about 0.01 of its potential returns per unit of risk. CG Oncology, Common is currently generating about 0.01 per unit of risk. If you would invest 80.00 in BriaCell Therapeutics Corp on September 3, 2024 and sell it today you would lose (37.00) from holding BriaCell Therapeutics Corp or give up 46.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.32% |
| Values | Daily Returns |
BriaCell Therapeutics Corp vs. CG Oncology, Common
Performance |
| Timeline |
| BriaCell Therapeutics |
| CG Oncology, Common |
BriaCell Therapeutics and CG Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BriaCell Therapeutics and CG Oncology,
The main advantage of trading using opposite BriaCell Therapeutics and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.| BriaCell Therapeutics vs. Briacell Therapeutics Corp | BriaCell Therapeutics vs. GeoVax Labs | BriaCell Therapeutics vs. immatics biotechnologies GmbH | BriaCell Therapeutics vs. CannBioRx Life Sciences |
| CG Oncology, vs. Paysafe | CG Oncology, vs. Sapiens International | CG Oncology, vs. VirnetX Holding Corp | CG Oncology, vs. Entravision Communications |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |